vs
Side-by-side financial comparison of BK Technologies Corp (BKTI) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
BK Technologies Corp is the larger business by last-quarter revenue ($21.5M vs $12.6M, roughly 1.7× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 19.7%, a 231.0% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 20.0%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -21.6%).
BK Technologies Corp designs, manufactures and sells analog and digital two-way radio communications equipment and related accessories. It serves public safety departments, first responders, government agencies and commercial clients primarily across North America, focusing on reliable, mission-critical communication solutions.
BKTI vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.5M | $12.6M |
| Net Profit | $4.2M | $31.5M |
| Gross Margin | 50.5% | — |
| Operating Margin | 19.7% | — |
| Net Margin | 19.7% | 250.7% |
| Revenue YoY | 20.0% | 24080.8% |
| Net Profit YoY | 15.6% | 250.9% |
| EPS (diluted) | $1.06 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.5M | $12.6M | ||
| Q3 25 | $24.4M | $0 | ||
| Q2 25 | $21.2M | $0 | ||
| Q1 25 | $19.1M | $12.0K | ||
| Q4 24 | $17.9M | $52.0K | ||
| Q3 24 | $20.2M | $65.0K | ||
| Q2 24 | $20.3M | $114.0K | ||
| Q1 24 | — | $140.0K |
| Q4 25 | $4.2M | $31.5M | ||
| Q3 25 | $3.4M | $-7.4M | ||
| Q2 25 | $3.7M | $-1.7M | ||
| Q1 25 | $2.1M | $-13.9M | ||
| Q4 24 | $3.7M | — | ||
| Q3 24 | $2.4M | $-17.1M | ||
| Q2 24 | $1.7M | $-17.9M | ||
| Q1 24 | — | $-12.7M |
| Q4 25 | 50.5% | — | ||
| Q3 25 | 49.9% | — | ||
| Q2 25 | 47.4% | — | ||
| Q1 25 | 47.0% | — | ||
| Q4 24 | 41.2% | — | ||
| Q3 24 | 38.8% | — | ||
| Q2 24 | 37.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | 19.7% | — | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 18.9% | — | ||
| Q1 25 | 15.3% | -122758.3% | ||
| Q4 24 | 12.3% | — | ||
| Q3 24 | 12.9% | -28604.6% | ||
| Q2 24 | 10.0% | -16720.2% | ||
| Q1 24 | — | -9987.1% |
| Q4 25 | 19.7% | 250.7% | ||
| Q3 25 | 14.1% | — | ||
| Q2 25 | 17.7% | — | ||
| Q1 25 | 11.2% | -115550.0% | ||
| Q4 24 | 20.4% | — | ||
| Q3 24 | 11.7% | -26380.0% | ||
| Q2 24 | 8.2% | -15668.4% | ||
| Q1 24 | — | -9049.3% |
| Q4 25 | $1.06 | $0.56 | ||
| Q3 25 | $0.87 | $-0.13 | ||
| Q2 25 | $0.96 | $-0.03 | ||
| Q1 25 | $0.55 | $-0.25 | ||
| Q4 24 | $0.96 | — | ||
| Q3 24 | $0.63 | $-0.32 | ||
| Q2 24 | $0.47 | $-0.33 | ||
| Q1 24 | — | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.8M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $44.7M | $59.0M |
| Total Assets | $63.8M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.8M | $40.3M | ||
| Q3 25 | $21.5M | $48.6M | ||
| Q2 25 | $11.9M | $31.2M | ||
| Q1 25 | $8.9M | $48.9M | ||
| Q4 24 | $7.1M | $52.9M | ||
| Q3 24 | $4.2M | $76.3M | ||
| Q2 24 | $3.0M | $63.5M | ||
| Q1 24 | — | $82.3M |
| Q4 25 | $44.7M | $59.0M | ||
| Q3 25 | $41.0M | $26.5M | ||
| Q2 25 | $36.8M | $32.8M | ||
| Q1 25 | $32.4M | $33.8M | ||
| Q4 24 | $29.8M | $46.1M | ||
| Q3 24 | $26.0M | $65.5M | ||
| Q2 24 | $23.4M | $80.5M | ||
| Q1 24 | — | $96.2M |
| Q4 25 | $63.8M | $68.9M | ||
| Q3 25 | $66.9M | $54.2M | ||
| Q2 25 | $60.4M | $62.1M | ||
| Q1 25 | $56.1M | $77.7M | ||
| Q4 24 | $51.5M | $110.5M | ||
| Q3 24 | $46.4M | $135.2M | ||
| Q2 24 | $48.9M | $149.9M | ||
| Q1 24 | — | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $-8.4M |
| Free Cash FlowOCF − Capex | $2.8M | — |
| FCF MarginFCF / Revenue | 13.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | 0.71× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $18.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $-8.4M | ||
| Q3 25 | $10.4M | $17.4M | ||
| Q2 25 | $3.9M | $-17.7M | ||
| Q1 25 | $2.1M | $-4.0M | ||
| Q4 24 | $3.8M | $-23.4M | ||
| Q3 24 | $5.7M | $12.8M | ||
| Q2 24 | $4.1M | $-18.7M | ||
| Q1 24 | — | $5.9M |
| Q4 25 | $2.8M | — | ||
| Q3 25 | $10.1M | — | ||
| Q2 25 | $3.7M | — | ||
| Q1 25 | $1.8M | — | ||
| Q4 24 | $3.4M | — | ||
| Q3 24 | $5.2M | — | ||
| Q2 24 | $3.9M | — | ||
| Q1 24 | — | — |
| Q4 25 | 13.2% | — | ||
| Q3 25 | 41.3% | — | ||
| Q2 25 | 17.3% | — | ||
| Q1 25 | 9.6% | — | ||
| Q4 24 | 19.2% | — | ||
| Q3 24 | 25.8% | — | ||
| Q2 24 | 19.2% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.71× | -0.26× | ||
| Q3 25 | 3.04× | — | ||
| Q2 25 | 1.04× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 2.40× | — | ||
| Q2 24 | 2.46× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
